Trial · NCT03285594
Results by group33
Each measurement the trial posted, group by group, in the words and numbers it posted.
21 to 33 of 33
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change From Baseline in Body Weight at Week 52 | Sotagliflozin 400 mg | -0.83 | Standard Error 0.374 | kg | |
| Percentage of Participants With Adverse Events (AEs) | Placebo | 64.6 | percentage of participants | ||
| Percentage of Participants With Adverse Events (AEs) | Sotagliflozin 200 mg | 54.6 | percentage of participants | ||
| Percentage of Participants With Adverse Events (AEs) | Sotagliflozin 400 mg | 59.3 | percentage of participants | ||
| Percentage of Participants With Hypoglycemic Events | Placebo | Any hypoglycemia | 62.5 | percentage of participants | |
| Percentage of Participants With Hypoglycemic Events | Sotagliflozin 200 mg | Any hypoglycemia | 56.0 | percentage of participants | |
| Percentage of Participants With Hypoglycemic Events | Sotagliflozin 400 mg | Any hypoglycemia | 62.8 | percentage of participants | |
| Percentage of Participants With Hypoglycemic Events | Placebo | Documented symptomatic hypoglycemia | 44.4 | percentage of participants | |
| Percentage of Participants With Hypoglycemic Events | Sotagliflozin 200 mg | Documented symptomatic hypoglycemia | 41.8 | percentage of participants | |
| Percentage of Participants With Hypoglycemic Events | Sotagliflozin 400 mg | Documented symptomatic hypoglycemia | 46 | percentage of participants | |
| Percentage of Participants With Hypoglycemic Events | Placebo | Severe or documented symptomatic hypoglycemia | 44.4 | percentage of participants | |
| Percentage of Participants With Hypoglycemic Events | Sotagliflozin 200 mg | Severe or documented symptomatic hypoglycemia | 41.8 | percentage of participants | |
| Percentage of Participants With Hypoglycemic Events | Sotagliflozin 400 mg | Severe or documented symptomatic hypoglycemia | 46 | percentage of participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03285594/results?page=2